The Global Fund in China: Multidrug-resistant tuberculosis nationwide programmatic scale-up and challenges to transition to full country ownership
Author:
Funder
Global Fund to Fight AIDS, Tuberculosis and Malaria
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference22 articles.
1. Global Tuberculosis Report 2016,2016
2. Global epidemiology of tuberculosis;P Glaziou;Semin Respir Crit Care Med,2013
3. National survey of drug-resistant tuberculosis in China;Y Zhao;N Engl J Med,2012
4. A new disease reporting system increases TB case detection in China;L Wan;Bull World Health Organ,2007
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Changing trend analysis on early detection of rifampicin resistant tuberculosis patients in southwestern area of China, 2016–2020;PLOS ONE;2023-11-16
2. Treatment outcomes of multidrug-resistant tuberculosis patients receiving ambulatory treatment in Shenzhen, China: a retrospective cohort study;Frontiers in Public Health;2023-06-20
3. The impacts of donor transitions on health systems in middle-income countries: a scoping review;Health Policy and Planning;2022-07-29
4. Time trend prediction and spatial–temporal analysis of multidrug-resistant tuberculosis in Guizhou Province, China, during 2014–2020;BMC Infectious Diseases;2022-06-07
5. Predictors and Trends of MDR/RR-TB in Shenzhen China: A Retrospective 2012–2020 Period Analysis;Infection and Drug Resistance;2021-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3